Final Programme CINP 2014 - page 61

Poster SESSIONS
61
Poster, 24 June 2014
Authors are asked to present their posters during the poster sessions.
P-23-013
Glutamate complex and BDNF concentra-
tion of depressive patients with cognitive
dysfunction
Changsu Han, Ansan City, Republic of Korea
S.-H. Kim
P-23-014
The alleged ineffectiveness of SSRIs in de-
pression is an artefact caused by the use of
an inappropriate measure of efficacy
Fredrik Hieronymus, Gothenburg, Sweden
J. F. Emilsson, S. Nilsson, E. Eriksson
P-23-015
Abnormality of fractional amplitude of low
frequency fluctuation (fALFF) in drug na-
ive patients with major depressive disorder
Manli Huang, Hangzhou, China
L. Yu, Y. Xu
P-23-016
Brain serotonin transporter may predict pa-
tient with suicide attempts in drug-naïve
major depressive disorder
San-Yuan Huang, Taiepi, Taiwan
Y.-W. Yeh, P.-S. Ho
P-23-017
A phase 3, long-term, open-label extension
study evaluating the safety and tolerability
of 15 and 20 mg vortioxetine in subjects with
major depressive disorder
Paula L. Jacobsen, Deerfield, USA
L. Harper, M. Serenko, S. Chan, A. R. Mahab-
leshwarkar
P-23-018
Initial response to medication predicts early
improvement after 2 weeks in patients with
major depressive disorder
Saeheon Jang, Busan, Republic of Korea
Y. Jae
P-23-019
The relationship between low self-esteem
and suicide attempt in patients with major
depressive disorder: A pilot study
Duk-In Jon, Anyang, Republic of Korea
H. Jeon, H. J. Hong, N. Hong, E.-H. Park,
M. H. Jung
P-23-020
Modelling the cycling of mood in a preclini-
cal model of depression
Lisa Kalynchuk, Saskatoon, Canada
K. Lebedeva, E. Fenton, H. Caruncho
P-23-021
Serum mirtazapine monitoring in the Korean
psychiatric patients
Jin Young Kim, Seoul, Republic of Korea
J.-H. Jang, W. Myung
P-23-022
Aripiprazole augmentation for major depres-
sive disorder: Dosing patterns in a natural-
istic treatment setting
Jungjin Kim, Seoul, Republic of Korea
S.-H. Kim, C.-U. Pae
P-23-023
Decreased quality of life in elderly patients
with subsyndromal depression
Moon-Doo Kim, Jeju, Republic of Korea
K.-H. Lee, S. Lee
P-23-024
Infanticide in psychiatry: Theoretical con-
cepts and clinical practice
Marian Kolenic, Presov, Slovak Republic
K. Moravcik, J. Pristasova
P-23-025
Female transgenic mice with conditional glu-
cocorticoid receptor deletion in noradrener-
gic system display depressive-like behavior
reversed by desipramine and fluoxetine
Grzegorz Kreiner, Krakow, Poland
P. Chmielarz, I. Nalepa
P-23-026
Molecular analysis of prefrontal cortex in
mice exposed to chronic mild stress; the in-
fluence on lipid and carbohydrate metabo-
lism under depressive state
Mikuni Motoyama, Nishinomiya, Hyogo, Japan
K. Yamanishi, N. Doe, M. Sumida, Y. Watanabe,
M. Yoshida, H. Yamamoto, W. Li, H. Yamanishi,
H. Okamura, H. Matsunaga
P-24
POSTER SESSION
17:15–18:45
Hall B
Eating disorders
P-24-001
Exploring cognitive function in obesity: As-
sessment of 5-choice serial reaction time
task performance in leptin-knockout rats
Wendy Adams, Vancouver, Canada
A. D´Souza, J. Sussman, T. Kieffer, C. Winstanley
1...,51,52,53,54,55,56,57,58,59,60 62,63,64,65,66,67,68,69,70,71,...120
Powered by FlippingBook